Advances in Chronic Kidney Disease
Volume 16, Issue 1 , Pages 52-59 , January 2009

Adjuvant Therapy After Surgical Stone Management

References 

  1. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817–1823
  2. Streem SB, Yost A, Mascha E. Clinical implications of clinically insignificant store fragments after extracorporeal shock wave lithotripsy. J Urol. 1996;155:1186–1190
  3. Raman JD, Gupta A, Bensalah K, et al. Natural history of residual fragments following percutaneous nephrostolithotomy. Presented at the AUA Annual Meeting, Chicago, April 2008 (abstract). J Urol. 2008;179:466
  4. Cicerello E, Merlo F, Gambaro G, et al. Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. J Urol. 1994;151:5–9
  5. Cicerello E, Merlo F, Maccatrozzo L, et al. Urolithiasis 2000. In:  Rodgers AL,  Hibbert BE,  Hess B, et al. editor. Effect of potassium citrate therapy on clearance of residual stone fragments after ESWL in calcium nephrolithiasis patients. Cape Town, South Africa: University of Cape Town; 2000;p. 592
  6. Soygur T, Akbay A, Kupeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol. 2002;16:149–152
  7. Arrabal-Martín M, Fernández-Rodríguez A, Arrabal-Polo MA, et al. Extracorporeal renal lithotripsy: Evolution of residual lithiasis treated with thiazides. Urology. 2006;68:956–959
  8. Hollingsworth JM, Rogers MA, Kaufman SR, et al. Medical therapy to facilitate urinary stone passage: A meta-analysis. Lancet. 2006;368:1171–1179
  9. Porpiglia F, Destefanis P, Fiori C, et al. Role of adjunctive medical therapy with nifedipine and deflazacort after extracorporeal shock wave lithotripsy of ureteral stones. Urology. 2002;59:835–838
  10. Sarica K, Inal Y, Erturhan S, et al. The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. Urol Res. 2006;34:184–189
  11. Gravina GL, Costa AM, Ronchi P, et al. Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology. 2005;66:24–28
  12. Bhagat SK, Chacko NK, Kekre NS, et al. Is there a role for tamsulosin in shock wave lithotripsy for renal and ureteral calculi?. J Urol. 2007;177:2185–2188
  13. Kupeli B, Irkilata L, Gurocak S, et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy?. Urology. 2004;64:1111–1115
  14. Sighinolfi MC, Micali S, Celia A, et al. Efficacy of expulsive therapy using nifedipine or tamsulosin, both associated with ketoprofene, after shock wave lithotripsy of ureteral stones. Urol Res. 2007;35:133–137
  15. Fine JK, Pak CY, Preminger GM. Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol. 1995;153:27–32
  16. Sarica K, Erturhan S, Yurtseven C, et al. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children. J Endourol. 2006;20:875–879
  17. Iguchi M, Ikegami M, Kiwamoto H, et al. Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers. Hinyokika Kiyo. 1993;39:425–431
  18. Sarica K, Bakir K, Yagci F, et al. Limitation of shockwave-induced enhanced crystal deposition in traumatized tissue by verapamil in rabbit model. J Endourol. 1999;13:343–347
  19. Jan CR, Chen WC, Wu SN, et al. Nifedipine, verapamil and diltiazem block shock-wave-induced rises in cytosolic calcium in MDCK cells. Chin J Physiol. 1998;41:181–188
  20. Strohmaier WL, Koch J, Balk N, et al. Limitation of shock-wave-induced renal tubular dysfunction by nifedipine. Eur Urol. 1994;25:99–104
  21. Delvecchio FC, Brizuela RM, Khan SR, et al. Citrate and vitamin E blunt the shock wave-induced free radical surge in an in vitro cell culture model. Urol Res. 2005;33:448–452
  22. Munver R, Delvecchio FC, Kuo RL, et al. In vivo assessment of free radical activity during shock wave lithotripsy using a microdialysis system: the renoprotective action of allopurinol. J Urol. 2002;167:327–334
  23. Biri H, Ozturk HS, Buyukkocak S, et al. Antioxidant defense potential of rabbit renal tissues after ESWL: Protective effects of antioxidant vitamins. Nephron. 1998;79:181–185
  24. Serel TA, Ozguner F, Soyupek S. Prevention of shock wave-induced renal oxidative stress by melatonin: An experimental study. Urol Res. 2004;32:69–71
  25. Thomas S, Ginsberg PC, Young LH, et al. Administration of protein kinase C bets II inhibitor during extracorporeal shock wave lithotripsy reduces free radical production. J Urol. 2008;179:498
  26. Ogiste JS, Nejat RJ, Rashid HH, et al. The role of mannitol in alleviating renal injury during extracorporeal shock wave lithotripsy. J Urol. 2003;169:875–877
  27. Micali S, Sighinolfi MC, Celia A, et al. Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study. J Urol. 2006;176:1020–1022
  28. Kosar A, Ozturk A, Serel TA, et al. Effect of vibration massage therapy after extracorporeal shockwave lithotripsy in patients with lower caliceal stones. J Endourol. 1999;13:705–707
  29. Pace KT, Tariq N, Dyer SJ, et al. Mechanical percussion, inversion and diuresis for residual lower pole fragments after shock wave lithotripsy: A prospective, single blind, randomized controlled trial. J Urol. 2001;166:2065–2071
  30. Chiong E, Hwee ST, Kay LM, Liang S, Kamaraj R, Esuvaranathan K. Randomized controlled study of mechanical percussion, diuresis, and inversion therapy to assist passage of lower pole renal calculi after shock wave lithotripsy. Urology. 2005;65:1070–1074
  31. Agah M, Falihi A. The efficacy of acupuncture in extracorporeal shock wave lithotripsy. Urol J. 2004;1:195–199
  32. Wang SM, Punjala M, Weiss D, et al. Acupuncture as an adjunct for sedation during lithotripsy. J Altern Complement Med. 2007;13:241–246
  33. Mora B, Iannuzzi M, Lang T, et al. Auricular acupressure as a treatment for anxiety before extracorporeal shock wave lithotripsy in the elderly. J Urol. 2007;178:160–164
  34. Roehrborn CG, Siami P, Barkin J, et al. Adjunctive tamsulosin improves stone free rate after ureeroscopic lithotripsy of large renal and ureteric calculi: A prospective randomized study. J Urol. 2008;179:616–621
  35. Schwalb DM, Eshghi M, Davidian M, et al. Morphological and physiological changes in the urinary tract associated with ureteral dilation and ureteropyeloscopy: An experimental study. J Urol. 1993;149:1576–1585
  36. Wilson WT, Preminger GM. Intrarenal pressures generated during flexible deflectable ureterorenoscopy. J Endourol. 1990;4:2–5
  37. Jung HU, Frimodt-Møller PC, Osther PJ, et al. Pharmacological effect on pyeloureteric dynamics with a clinical perspective: A review of the literature. Urol Res. 2006;34:341–350
  38. Selmy GI, Hassouna MM, Khalaf IM, et al. Effects of verapamil, prostaglandin F2 alpha, phenylephrine, and noradrenaline on upper urinary tract dynamics. Urology. 1994;43:31–35
  39. Weiss R, Mevissen M, Hauser DS, et al. Inhibition of human and pig ureter motility in vitro and in vivo by the K(+) channel openers PKF 217–744b and nicorandil. J Pharmacol Exp Ther. 2002;302:651–658
  40. Jakobsen JS, Holst U, Jakobsen P, et al. Local and systemic effects of endoluminal pelvic perfusion of isoproterenol: A dose response investigation in pigs. JUrol. 2007;177:1934–1938
  41. Jung HU, Jakobsen JS, Mortensen J, et al. Irrigation with isoproterenol diminishes increases in pelvic pressure without side-effects during ureterorenoscopy: A randomized controlled study in a porcine model. Scand J Urol Nephrol. 2008;42:7–11
  42. Kang DE, Maloney MM, Haleblian GE, et al. Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy. J Urol. 2007;177:1785–1788
  43. Norris RD, Sur RL, Springhart WP, et al. A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort. Urology. 2008;71:792–795
  44. Beddingfield R, Pedro R, Hinck B, et al. Alfuzosin to relieve ureteral stent discomfort: A randiomized placebo-controlled study (AUA abstract 1461). J Urol. 2008;176:499
  45. Park SC, Lee JW, Seo IY, et al. The effect of alfuzosin and tolterodine in treating double-J stent-related symptoms (AUA abstract 816). J Urol. 2008;179:289
  46. Beiko DT, Watterson JD, Knudsen BE, et al. Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy. J Endourol. 2004;18:723–7330
  47. Lehtoranta K, Mankinen P, Taari K, et al. Residual stones after percutaneous nephrolithotomy; sensitivities of different imaging methods in renal stone detection. Ann Chir Gynaecol. 1995;84:43–49
  48. Pearle MS, Watamull LM, Mullican MA. Sensitivity of noncontrast helical computerized tomography and plain film radiography compared to flexible nephroscopy for detecting residual fragments after percutaneous nephrostolithotomy. J Urol. 1999;162:23–26
  49. Bensalah K, Tuncel A, Gupta A, et al. Determinants of quality of life for patients with kidney stones. J Urol. 2008;179:2238–2243

PII: S1548-5595(08)00171-7

doi: 10.1053/j.ackd.2008.10.007

Advances in Chronic Kidney Disease
Volume 16, Issue 1 , Pages 52-59 , January 2009

Article Tools